蓝帆医疗股份有限公司第六届董事会第三十三次会议决议公告

Core Viewpoint - The company has decided to lower the conversion price of its convertible bonds, "蓝帆转债," to 10.00 CNY per share, effective from November 10, 2025, following the approval from the board and shareholders [2][18]. Group 1: Board Meeting and Decision - The sixth board meeting of the company was held on November 7, 2025, where the proposal to adjust the conversion price was discussed and approved [1][2]. - The average trading price of the company's stock was 5.58 CNY per share over the twenty trading days prior to the shareholder meeting, and 5.52 CNY on the last trading day before the meeting [2][18]. - The board's decision to lower the conversion price was based on the company's future development prospects and stock price trends [2][18]. Group 2: Convertible Bond Details - The company issued 31.44 million convertible bonds in May 2020, with a total value of 314.404 million CNY [8][9]. - The previous conversion price was set at 10.50 CNY per share before the recent adjustment [8]. - The conversion period for the bonds is from December 3, 2020, to May 27, 2026 [10]. Group 3: Shareholder Meeting and Voting - The fifth extraordinary general meeting of shareholders took place on November 7, 2025, where the proposal to adjust the conversion price was approved with a significant majority [21][31]. - The voting results showed that 96.15% of the attending shareholders supported the proposal [31]. - The company ensured that the voting process respected the interests of minority investors by counting their votes separately [22].